
Oragenics, Inc.
OGENAMEXHealthcare● Active
$0.60
+$0.00(+0.00%)
Market Cap$2727027
P/E Ratio—
52W High$5.19
52W Low$0.5
Oragenics, Inc. (OGEN) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · OGEN · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($9.84B) | ($0.01B) | ($0.02B) | ($0.01B) | ($0.02B) |
| Depreciation & Amort. | $0.77B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.64B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | ($0.00B) | $0.00B | $0.00B | ($0.00B) | $0.00B |
| Net Cash from Operations | ($9.25B) | ($0.01B) | ($0.01B) | ($0.02B) | ($0.01B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | $0.00B | ($0.00B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | $0.00B | $0.00B | ($0.00B) | ($0.00B) | ($0.00B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | ($0.01B) |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Debt Issued / Repaid | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Net Cash from Financing | $16.78B | $0.01B | $0.00B | ($0.00B) | $0.02B |
| Free Cash Flow | |||||
| Free Cash Flow | ($9.25B) | ($0.01B) | ($0.01B) | ($0.02B) | ($0.01B) |
| FCF Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Oragenics, Inc. data
About Oragenics, Inc. (OGEN) Cash Flow Statement
Oragenics, Inc. generated operating cash flow of ($9.25B) and free cash flow of ($9.25B) for 2025 — a FCF margin of —. Capital expenditure was ($0.00B).
Frequently asked questions
OGEN · 4 questionsOragenics, Inc. generated free cash flow of ($9.25B) for 2025, down 107448.9% year-over-year.
OGEN free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10